Innealta Capital’s iRadimed IRMD Stock Holding History

Innealta Capital’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12	Closed	-$527	–	908
2024 Q2	$527	Buy	+12	New	+$510	﹤0.01%	1464

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Innealta Capital's IRMD Position: Q3 2024 in Review

Innealta Capital sold out of iRadimed (IRMD) in Q3 2024, closing a stake of 12 shares — an estimated $527 sold.

Innealta Capital first reported a position in IRMD in Q2 2024 and held it in 1 quarter. The position peaked at $527 in Q2 2024. 145 funds tracked by Wall St. Rank hold IRMD as of Q3 2024.

Innealta Capital reported no remaining iRadimed position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 12 iRadimed shares in Q3 2024, an estimated $527.
Innealta Capital first reported a position in iRadimed in Q2 2024 and held it in 1 quarter.
Innealta Capital's iRadimed position peaked at $527 in Q2 2024.
145 funds tracked by Wall St. Rank held iRadimed as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.